P3 Health Partners Statistics
Share Statistics
P3 Health Partners has 6.38B
shares outstanding. The number of shares has increased by 179.41%
in one year.
Shares Outstanding | 6.38B |
Shares Change (YoY) | 179.41% |
Shares Change (QoQ) | -19.18% |
Owned by Institutions (%) | 3.72% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 180 |
FTD / Avg. Volume | 0.47% |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -0.24 and the forward
PE ratio is null.
P3 Health Partners's PEG ratio is
0.
PE Ratio | -0.24 |
Forward PE | n/a |
PS Ratio | 0.02 |
Forward PS | 0 |
PB Ratio | 0.43 |
P/FCF Ratio | -0.3 |
PEG Ratio | 0 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for P3 Health Partners.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.37,
with a Debt / Equity ratio of 2.19.
Current Ratio | 0.37 |
Quick Ratio | 0.37 |
Debt / Equity | 2.19 |
Debt / EBITDA | -0.84 |
Debt / FCF | -1.51 |
Interest Coverage | -14.1 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $4,167,930.56 |
Profits Per Employee | $-377,358.33 |
Employee Count | 360 |
Asset Turnover | 1.92 |
Inventory Turnover | n/a |
Taxes
Income Tax | 4.39M |
Effective Tax Rate | -1.43% |
Stock Price Statistics
The stock price has increased by -84.59% in the
last 52 weeks. The beta is 0.95, so P3 Health Partners's
price volatility has been higher than the market average.
Beta | 0.95 |
52-Week Price Change | -84.59% |
50-Day Moving Average | 0.01 |
200-Day Moving Average | 0.06 |
Relative Strength Index (RSI) | 41.76 |
Average Volume (20 Days) | 38,410 |
Income Statement
In the last 12 months, P3 Health Partners had revenue of 1.5B
and earned -135.85M
in profits. Earnings per share was -0.94.
Revenue | 1.5B |
Gross Profit | -144.97M |
Operating Income | -312.6M |
Net Income | -135.85M |
EBITDA | -197.76M |
EBIT | -283.82M |
Earnings Per Share (EPS) | -0.94 |
Full Income Statement Balance Sheet
The company has 38.82M in cash and 166.16M in
debt, giving a net cash position of -127.35M.
Cash & Cash Equivalents | 38.82M |
Total Debt | 166.16M |
Net Cash | -127.35M |
Retained Earnings | -503.19M |
Total Assets | 783.42M |
Working Capital | -312.27M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -110.13M
and capital expenditures 0, giving a free cash flow of -110.13M.
Operating Cash Flow | -110.13M |
Capital Expenditures | n/a |
Free Cash Flow | -110.13M |
FCF Per Share | -0.76 |
Full Cash Flow Statement Margins
Gross margin is -9.66%, with operating and profit margins of -20.83% and -9.05%.
Gross Margin | -9.66% |
Operating Margin | -20.83% |
Pretax Margin | -20.39% |
Profit Margin | -9.05% |
EBITDA Margin | -13.18% |
EBIT Margin | -20.83% |
FCF Margin | -7.34% |